IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $316,402,485 | -12.5% | 6,096,387 | +1.1% | 6.68% | -3.0% |
Q2 2023 | $361,536,795 | +29.4% | 6,029,633 | +6.7% | 6.88% | +18.3% |
Q1 2023 | $279,333,182 | -12.0% | 5,649,943 | +1.6% | 5.82% | -10.2% |
Q4 2022 | $317,270,507 | +51.8% | 5,559,322 | +24.9% | 6.48% | +34.5% |
Q3 2022 | $208,953,000 | +40.1% | 4,451,483 | +11.4% | 4.82% | +25.1% |
Q2 2022 | $149,097,000 | +168.2% | 3,996,154 | +114.9% | 3.85% | +234.7% |
Q1 2022 | $55,598,000 | +30.4% | 1,859,471 | +49.3% | 1.15% | +84.8% |
Q4 2021 | $42,647,000 | -7.6% | 1,245,532 | 0.0% | 0.62% | -10.5% |
Q3 2021 | $46,172,000 | -3.6% | 1,245,532 | 0.0% | 0.70% | -3.7% |
Q2 2021 | $47,888,000 | -4.5% | 1,245,532 | 0.0% | 0.72% | -7.7% |
Q1 2021 | $50,142,000 | – | 1,245,532 | – | 0.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 576,923 | $29,942,304 | 35.70% |
RTW INVESTMENTS, LP | 6,096,387 | $316,402,485 | 6.68% |
Paradigm Biocapital Advisors LP | 1,384,686 | $71,865,203 | 4.88% |
Rock Springs Capital Management LP | 2,943,710 | $152,778,549 | 4.09% |
Logos Global Management LP | 450,000 | $23,355,000 | 3.12% |
TANG CAPITAL MANAGEMENT LLC | 405,600 | $21,050,640 | 2.97% |
GREAT POINT PARTNERS LLC | 290,917 | $15,098,592 | 2.75% |
Nicholas Investment Partners, LP | 512,855 | $26,617,175 | 1.99% |
Eschler Asset Management LLP | 30,000 | $1,557,000 | 1.82% |
COWEN AND COMPANY, LLC | 460,036 | $23,875,868 | 1.67% |